TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 6 | 10 | 6 | 7 | -6 | 75 | 16 |
| P | %wins | 67 | 67 | 67 | 67 | 33 | 33 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/28/17 16:31 | 6/19/17 | ATNX | Athenex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riehle J Nick | NY | O | CFO | P.a | 17 | 11.00 | 0 | 2 | New | 2 | D | ||||||||||||||
11/5/10 16:59 | 11/4/10 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Riehle J Nick | NC | O | CFO | P.d | 14 | 4.83 | 3 | 3 | 5 | 66 | D | 173 | 117 | 35 | 73 | -13 | -7 | 0 | 0 | -1 | -2 | 11 | 1 | -10 | -2 |
12/22/09 11:48 | 12/21/09 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Riehle J Nick | NC | O | CFO | P.d | 6 | 2.20 | 1 | 3 | 4 | 63 | D | -65 | 92 | -49 | -68 | -1 | -12 | 5 | 0 | 5 | 23 | 27 | 76 | 38 | 231 |
9/25/08 14:22 | 9/25/08 | CHTP | Chelsea Therapeutics International, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Riehle J Nick | NC | O | CFO | P.d | 6 | 3.18 | 0 | 2 | 3 | 61 | D | -15 | -55 | -49 | -48 | -48 | -39 | -38 | -13 | 13 | 9 | -20 | -56 | -46 | -3 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |